Aileron Therapeutics Inc (ALRN)
3.90
+0.14
(+3.72%)
USD |
NASDAQ |
May 06, 13:00
Aileron Therapeutics Cash from Operations (TTM): -19.81M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -19.81M |
| September 30, 2023 | -13.83M |
| June 30, 2023 | -19.16M |
| March 31, 2023 | -21.73M |
| December 31, 2022 | -24.86M |
| September 30, 2022 | -26.71M |
| June 30, 2022 | -27.00M |
| March 31, 2022 | -25.08M |
| December 31, 2021 | -23.75M |
| September 30, 2021 | -22.19M |
| June 30, 2021 | -19.97M |
| March 31, 2021 | -21.28M |
| December 31, 2020 | -20.48M |
| September 30, 2020 | -22.09M |
| June 30, 2020 | -24.02M |
| Date | Value |
|---|---|
| March 31, 2020 | -24.64M |
| December 31, 2019 | -26.47M |
| September 30, 2019 | -26.83M |
| June 30, 2019 | -26.73M |
| March 31, 2019 | -28.50M |
| December 31, 2018 | -27.93M |
| September 30, 2018 | -27.10M |
| June 30, 2018 | -25.46M |
| March 31, 2018 | -21.51M |
| December 31, 2017 | -20.53M |
| September 30, 2017 | -18.93M |
| June 30, 2017 | -17.62M |
| March 31, 2017 | -17.22M |
| December 31, 2016 | -15.01M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-27.00M
Minimum
Jun 2022
-13.83M
Maximum
Sep 2023
-22.98M
Average
-23.75M
Median
Dec 2021
Cash from Operations (TTM) Benchmarks
| EyePoint Pharmaceuticals Inc | 1.875M |
| INVO Bioscience Inc | -4.755M |
| Bio-Path Holdings Inc | -11.54M |
| SINTX Technologies Inc | -14.12M |
| NovaBay Pharmaceuticals Inc | -4.131M |